Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $6.32 | Prev. Close $6.24 | Circuit Range N/A |
Day Range $6.32 - $6.64 | Year Range $0.24 - $7.49 | Volume 5,793 |
Average Traded $6.51 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $6.42 | $6.21 | -3.72% |
17-Mar-26 | $6.30 | $6.45 | +4.54% |
16-Mar-26 | $6.00 | $6.17 | +4.05% |
13-Mar-26 | $6.14 | $5.93 | -3.66% |
12-Mar-26 | $6.18 | $6.16 | -2.46% |
11-Mar-26 | $6.65 | $6.31 | -4.32% |
10-Mar-26 | $6.94 | $6.59 | -7.89% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?